Stockreport

Supernus Pharmaceuticals Inc (SUPN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF Operating Earnings (GAAP): $40.9 million for Q3 2024, up from $8.1 million in Q3 2023. Net Earnings (GAAP): $38.5 million for Q3 2024, or $0.69 per diluted share, com [Read more]